| Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer International Adjuvant Lung Cancer Trial Collaborative Group New England Journal of Medicine 350 (4), 351-360, 2004 | 3000 | 2004 |
| Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20 DK Wyld, P Selby, TJ Perren, SK Jonas, TG Allen‐Mersh, J Wheeldon, ... International journal of cancer 79 (3), 288-293, 1998 | 188 | 1998 |
| Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial MR Stockler, R O'Connell, AK Nowak, D Goldstein, J Turner, ... The lancet oncology 8 (7), 603-612, 2007 | 165 | 2007 |
| Cisplatin‐based therapy: a neurological and neuropsychological review L Troy, K McFarland, S Littman‐Power, BJ Kelly, ET Walpole, D Wyld, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2000 | 164 | 2000 |
| Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study A Molassiotis, P Yates, Q Li, WKW So, K Pongthavornkamol, P Pittayapan, ... Annals of Oncology 28 (10), 2552-2558, 2017 | 140 | 2017 |
| Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and KRAS-Specific Results of the NCIC CTG and … HJ Au, CS Karapetis, CJ O'Callaghan, D Tu, MJ Moore, JR Zalcberg, ... Journal of Clinical Oncology 27 (11), 1822-1828, 2009 | 127 | 2009 |
| Prognostic gene expression signature for high-grade serous ovarian cancer J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ... Annals of oncology 31 (9), 1240-1250, 2020 | 104 | 2020 |
| Anxiety, depression and quality of life in people with pancreatic cancer and their carers M Janda, RE Neale, K Klein, DL O'Connell, H Gooden, D Goldstein, ... Pancreatology 17 (2), 321-327, 2017 | 97 | 2017 |
| Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors S Singh, L Moody, DL Chan, DC Metz, J Strosberg, T Asmis, DL Bailey, ... JAMA oncology 4 (11), 1597-1604, 2018 | 85 | 2018 |
| Phase I biodistribution and pharmacokinetic study of Lewis Y–targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers RA Herbertson, NC Tebbutt, FT Lee, DJ MacFarlane, B Chappell, ... Clinical Cancer Research 15 (21), 6709-6715, 2009 | 85 | 2009 |
| Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated antitumor immunity in mice E Ahern, H Harjunpää, D Barkauskas, S Allen, K Takeda, H Yagita, ... Clinical Cancer Research 23 (19), 5789-5801, 2017 | 81 | 2017 |
| Respiratory bronchiolitis‐associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy M Flower, L Nandakumar, M Singh, D Wyld, M Windsor, D Fielding Respirology case reports 5 (3), e00230, 2017 | 81 | 2017 |
| Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study MJ Newton, SC Hayes, M Janda, PM Webb, A Obermair, EG Eakin, ... BMC cancer 11, 1-9, 2011 | 78 | 2011 |
| Carboplatin and etoposide combined with bevacizumab for the treatment of recurrent glioblastoma multiforme AB Francesconi, S Dupre, M Matos, D Martin, BG Hughes, DK Wyld, ... Journal of Clinical Neuroscience 17 (8), 970-974, 2010 | 75 | 2010 |
| A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services VL Beesley, M Janda, D Goldstein, H Gooden, ND Merrett, DL O'Connell, ... Psycho‐Oncology 25 (2), 150-157, 2016 | 74 | 2016 |
| A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma R Kefford, JMN Beith, GA Van Hazel, M Millward, JM Trotter, DK Wyld, ... Investigational new drugs 25, 247-252, 2007 | 70 | 2007 |
| A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma R Kefford, JMN Beith, GA Van Hazel, M Millward, JM Trotter, DK Wyld, ... Investigational new drugs 25, 247-252, 2007 | 70 | 2007 |
| Hemoglobin, body mass index, and age as risk factors for paclitaxel-and oxaliplatin-induced peripheral neuropathy D Mizrahi, SB Park, T Li, HC Timmins, T Trinh, K Au, E Battaglini, D Wyld, ... JAMA network open 4 (2), e2036695-e2036695, 2021 | 65 | 2021 |
| Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised … RJ Chan, S Northfield, E Larsen, G Mihala, A Ullman, P Hancock, ... Trials 18, 1-13, 2017 | 64 | 2017 |
| The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates BE Kiely, AJ Martin, MHN Tattersall, AK Nowak, D Goldstein, ... Journal of clinical oncology 31 (28), 3565-3571, 2013 | 59 | 2013 |
Monika JandaThe University of Queensland and Queensland University of TechnologyVerified email at qut.edu.au
